Aridis' mon­o­clon­al an­ti­body fails PhI­II, but plans for sec­ond tri­al any­way

Aridis Phar­ma­ceu­ti­cals’ mon­o­clon­al an­ti­body missed the bar in a Phase III test in ven­ti­la­tor-as­so­ci­at­ed pneu­mo­nia caused by the gram-pos­i­tive bac­te­ria S. au­reus,

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER